Senzar Asset Management as of March 31, 2017
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 28 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sanofi-Aventis SA (SNY) | 17.6 | $70M | 1.5M | 45.26 | |
| Halozyme Therapeutics (HALO) | 11.5 | $45M | 3.5M | 12.96 | |
| Express Scripts Holding | 8.7 | $35M | 523k | 65.89 | |
| Anthem (ELV) | 7.2 | $28M | 171k | 165.50 | |
| Gilead Sciences (GILD) | 5.5 | $22M | 321k | 67.89 | |
| Bioverativ Inc Com equity | 4.8 | $19M | 344k | 54.48 | |
| Abbott Laboratories (ABT) | 4.3 | $17M | 387k | 44.41 | |
| MiMedx (MDXG) | 4.1 | $16M | 1.7M | 9.53 | |
| Tg Therapeutics (TGTX) | 3.4 | $13M | 1.1M | 11.65 | |
| Globus Med Inc cl a (GMED) | 3.4 | $13M | 447k | 29.62 | |
| Forward Pharma A/s | 2.6 | $10M | 472k | 21.52 | |
| Myriad Genetics (MYGN) | 2.5 | $10M | 519k | 19.20 | |
| LifePoint Hospitals | 2.4 | $9.4M | 143k | 65.59 | |
| Select Medical Holdings Corporation (SEM) | 2.2 | $8.9M | 662k | 13.38 | |
| Tenet Healthcare Corporation (THC) | 2.2 | $8.6M | 484k | 17.74 | |
| Neuroderm Ltd F | 2.2 | $8.6M | 324k | 26.49 | |
| Mylan Nv | 2.1 | $8.5M | 217k | 39.02 | |
| Retrophin | 2.0 | $7.9M | 430k | 18.43 | |
| Orthofix International Nv Com Stk | 1.8 | $7.2M | 189k | 38.18 | |
| Concert Pharmaceuticals I equity | 1.8 | $7.1M | 417k | 17.06 | |
| Diplomat Pharmacy | 1.8 | $7.1M | 445k | 15.94 | |
| Corium Intl | 1.6 | $6.3M | 1.5M | 4.17 | |
| Alder Biopharmaceuticals | 1.1 | $4.5M | 215k | 20.78 | |
| Momenta Pharmaceuticals | 1.1 | $4.2M | 313k | 13.38 | |
| Arena Pharmaceuticals | 0.7 | $2.9M | 2.0M | 1.47 | |
| Foamix Pharmaceuticals | 0.7 | $2.8M | 575k | 4.92 | |
| Inotek Pharmaceuticals | 0.4 | $1.7M | 852k | 1.98 | |
| Aviragen Therapeutics | 0.3 | $1.1M | 1.7M | 0.66 |
